Reapplix receives new reimbursement coding and completes USD 22.6M equity financing to drive US commercialisation

Reapplix announces that it has successfully received Medicare reimbursement coding instructions from the Centers for Medicare and Medicaid Services (CMS) with a national average payment rate of USD 1,622.74. The rate covers each patient visit to Hospital Outpatient Departments to receive 3C Patch® therapy for hard-to-heal diabetic foot ulcers.

Reapplix also announces that it has successfully closed a USD 22.6M (DKK 150M) equity financing round, primarily to accelerate the US commercialization of 3C Patch® (

Read more

By Optimum

For more information about Optimum Strategic Communications, please get in touch

We'd love to hear from you...